💉 The Oxford coronavirus vaccine has been shown to trigger a robust immune response in healthy adults aged 56-69 and 70+. The data suggest that one of the groups most vulnerable to serious illness and death from COVID-19 could build immunity:
https://t.co/E5uEcHFcrT
#OxfordVaccine
https://t.co/E5uEcHFcrT
#OxfordVaccine
www.ox.ac.uk
Oxford coronavirus vaccine produces strong immune response in older adults | University of Oxford
The ChAdOx1 nCov-2019 coronavirus vaccine, developed by teams at the University of Oxford, has been shown to trigger a robust immune response in healthy adults aged 56-69 and those over 70 years of age. The data, published today in The Lancet, suggest that…
💉 واکسن آکسفورد:
Interim data show the #OxfordVaccine is 70.4% effective, & tests on two dose regimens show that it could be 90%, moving us one step closer to supplying it at low cost around the world>>
https://t.co/fnHnKSqftT
Interim data show the #OxfordVaccine is 70.4% effective, & tests on two dose regimens show that it could be 90%, moving us one step closer to supplying it at low cost around the world>>
https://t.co/fnHnKSqftT
www.ox.ac.uk
Oxford University breakthrough on global COVID-19 vaccine | University of Oxford
The University of Oxford, in collaboration with AstraZeneca plc, today announces interim trial data from its Phase III trials that show its candidate vaccine, ChAdOx1 nCoV-2019, is effective at preventing COVID-19 (SARS-CoV-2) and offers a high level of protection.
💉 VACCINE UPDATE:
New study shows that the #OxfordVaccine offers protection of 76% up to 12 weeks after a single dose, with further data supporting a 4-12 week dosing interval.
Further analysis also shows that the #OxfordVaccine may have a substantial effect on coronavirus transmission, with 67% reduction in positive PCR swabs among those who have been vaccinated: https://t.co/7aZAWgFqQH
New study shows that the #OxfordVaccine offers protection of 76% up to 12 weeks after a single dose, with further data supporting a 4-12 week dosing interval.
Further analysis also shows that the #OxfordVaccine may have a substantial effect on coronavirus transmission, with 67% reduction in positive PCR swabs among those who have been vaccinated: https://t.co/7aZAWgFqQH
www.ox.ac.uk
Oxford coronavirus vaccine shows sustained protection of 76% during the 3-month interval until the second dose | University of…
Analyses reveal single standard dose efficacy from day 22 to day 90 post vaccination of 76% with protection not falling in this three-month periodAfter the second dose vaccine efficacy from two standard doses is 82.4% with the 3-month interval being used…
💉 📽️ Video for the kids - what is a vaccine and how do they work?
#OxfordVaccine.
Watch https://t.co/DuwlWIhf1l
#OxfordVaccine.
Watch https://t.co/DuwlWIhf1l
YouTube
What is a vaccine & how do they work? (with UKRI) | #80 Let's Go Live with Maddie & Greg
**CHECK OUT OUR NEW SCIENCE ACTIVITIES WEBSITE - https://letsgolivescience.com/ - forindividual activity pages with video clips, kit lists, methods, and scie...
💉 #COVID19 good news 👏
A study analysing 373,402 participants finds COVID-19 infections fell significantly after a single dose of the #OxfordVaccine or Pfizer jab.
More info ⬇️
https://www.ox.ac.uk/news/2021-04-23-significant-reductions-covid-19-infections-found-after-single-dose-oxford
A study analysing 373,402 participants finds COVID-19 infections fell significantly after a single dose of the #OxfordVaccine or Pfizer jab.
More info ⬇️
https://www.ox.ac.uk/news/2021-04-23-significant-reductions-covid-19-infections-found-after-single-dose-oxford
www.ox.ac.uk
Significant reductions in COVID-19 infections found after single dose of Oxford-AstraZeneca and Pfizer-BioNTech vaccine | University…
COVID-19 infections fell significantly – by 65% percent - after a first dose of the Oxford-AstraZeneca or Pfizer-BioNTech vaccines in this large community surveillance study.